Journal of virology

(J Virol) ISSNs: , 1098-5514

References in Journal of virology:

Search this table:

Title	Authors	Year
Effect of the human immunodeficiency virus type 1 reverse transcriptase polymorphism Leu-214 on replication capacity and drug susceptibility.	Puertas MC, Buzón MJ, Artese A, Alcaro S, Menéndez-Arias L, Perno CF, Clotet B, Ceccherini-Silberstein F, Martinez-Picado J	2009
Separation of a new deoxyribonucleic acid polymerase from vaccinia-infected HeLa cells.	Berns KI, Silverman C, Weissbach A	1969
DNA polymerase associated with human hepatitis B antigen.	Kaplan PM, Greenman RL, Gerin JL, Purcell RH, Robinson WS	1973
Exonuclease associated with bacteriophage T5-Induced DNA polymerase.	Das SK, Fujimura RK	1976
Autographa californica nuclear polyhedrosis virus DNA polymerase: measurements of processivity and strand displacement.	McDougal VV, Guarino LA	1999
Strand displacement synthesis capability of Moloney murine leukemia virus reverse transcriptase.	Whiting SH, Champoux JJ	1994
DNA polymerase in the core of the human hepatitis B virus candidate.	Robinson WS, Greenman RL	1974
Human Cytomegalovirus UL44 Concentrates at the Periphery of Replication Compartments, the Site of Viral DNA Synthesis.	Strang BL, Boulant S, Chang L, Knipe DM, Kirchhausen T, Coen DM	2011
Studies on vaccinia virus-directed deoxyribonucleic acid polymerase.	Citarella RV, Muller R, Schlabach A, Weissbach A	1972
DNA of a human hepatitis B virus candidate.	Robinson WS, Clayton DA, Greenman RL	1974
RNA-dependent DNA polymerase activity of RNA tumor virus. VI. Processive mode of action of avian myeloblastosis virus polymerase.	Leis JP	1976
Mouse DNA primase plays the principal role in determination of permissiveness for polyomavirus DNA replication.	Eki T, Enomoto T, Masutani C, Miyajima A, Takada R, Murakami Y, Ohno T, Hanaoka F, Ui M	1991
Mechanism of inhibition of herpes simplex virus and vaccinia virus DNA polymerases by aphidicolin, a highly specific inhibitor of DNA replication in eucaryotes.	Pedrali-Noy G, Spadari S	1980
RNA-dependent DNA polymerase activity of RNA tumor viruses. V. Rous sarcoma virus single-stranded RNA-DNA covalent hybrids in infected chicken embryo fibroblast cells.	Leis J, Schincariol A, Ishizaki R, Hurwitz J	1975
Rescue of bacteriophage T7 DNA polymerase of low processivity by suppressor mutations affecting gene 3 endonuclease.	Lee SJ, Chowdhury K, Tabor S, Richardson CC	2009
Pathogenicity of herpes simplex virus mutants containing drug resistance mutations in the viral DNA polymerase gene.	Field HJ, Coen DM	1986
Rolling circle DNA replication by extracts of herpes simplex virus type 1-infected human cells.	Skaliter R, Makhov AM, Griffith JD, Lehman IR	1996
Foamy retrovirus integrase contains a Pol dimerization domain required for protease activation.	Lee EG, Roy J, Jackson D, Clark PK, Boyer PL, Hughes SH, Linial ML	2011
Characterization of the polymerase and RNase H activities of human foamy virus reverse transcriptase.	Boyer PL, Stenbak CR, Clark PK, Linial ML, Hughes SH	2004
Mutation of the catalytic domain of the foamy virus reverse transcriptase leads to loss of processivity and infectivity.	Rinke CS, Boyer PL, Sullivan MD, Hughes SH, Linial ML	2002
Effects of amino acid substitutions at position 115 on the fidelity of human immunodeficiency virus type 1 reverse transcriptase.	Boyer PL, Hughes SH	2000
Replication of phenotypically mixed human immunodeficiency virus type 1 virions containing catalytically active and catalytically inactive reverse transcriptase.	Julias JG, Ferris AL, Boyer PL, Hughes SH	2001
Studies of the genomic RNA of leukosis viruses: implications for RNA dimerization.	Ortiz-Conde BA, Hughes SH	1999
Subunit-specific mutagenesis of the cysteine 280 residue of the reverse transcriptase of human immunodeficiency virus type 1: effects on sensitivity to a specific inhibitor of the RNase H activity.	Loya S, Gao HQ, Avidan O, Boyer PL, Hughes SH, Hizi A	1997
Analysis of nonnucleoside drug-resistant variants of human immunodeficiency virus type 1 reverse transcriptase.	Boyer PL, Currens MJ, McMahon JB, Boyd MR, Hughes SH	1993
Mutational analysis of the fingers domain of human immunodeficiency virus type 1 reverse transcriptase.	Boyer PL, Ferris AL, Hughes SH	1992
Cassette mutagenesis of the reverse transcriptase of human immunodeficiency virus type 1.	Boyer PL, Ferris AL, Hughes SH	1992
Nature, position, and frequency of mutations made in a single cycle of HIV-1 replication.	Abram ME, Ferris AL, Shao W, Alvord WG, Hughes SH	2010
The effects of alternate polypurine tracts (PPTs) and mutations of sequences adjacent to the PPT on viral replication and cleavage specificity of the Rous sarcoma virus reverse transcriptase.	Chang KW, Oh J, Alvord WG, Hughes SH	2008
Mutations in the U5 region adjacent to the primer binding site affect tRNA cleavage by human immunodeficiency virus type 1 reverse transcriptase in vivo.	Oh J, McWilliams MJ, Julias JG, Hughes SH	2008
In vitro characterization of a simian immunodeficiency virus-human immunodeficiency virus (HIV) chimera expressing HIV type 1 reverse transcriptase to study antiviral resistance in pigtail macaques.	Ambrose Z, Boltz V, Palmer S, Coffin JM, Hughes SH, Kewalramani VN	2004
Cross-linking of the fingers subdomain of human immunodeficiency virus type 1 reverse transcriptase to template-primer.	Peletskaya EN, Boyer PL, Kogon AA, Clark PK, Kroth H, Sayer JM, Jerina DM, Hughes SH	2001
Redesignation of the RNase D activity associated with retroviral reverse transcriptase as RNase H.	Hostomsky Z, Hughes SH, Goff SP, Le Grice SF	1994
Human immunodeficiency virus type 1 nucleocapsid protein can prevent self-priming of minus-strand strong stop DNA by promoting the annealing of short oligonucleotides to hairpin sequences.	Driscoll MD, Hughes SH	2000
Mutations in the thumb allow human immunodeficiency virus type 1 reverse transcriptase to be cleaved by protease in virions.	Dunn LL, McWilliams MJ, Das K, Arnold E, Hughes SH	2009
The hepatitis B virus polymerase mutation rtV173L is selected during lamivudine therapy and enhances viral replication in vitro.	Delaney WE, Yang H, Westland CE, Das K, Arnold E, Gibbs CS, Miller MD, Xiong S	2003
The level of reverse transcriptase (RT) in human immunodeficiency virus type 1 particles affects susceptibility to nonnucleoside RT inhibitors but not to lamivudine.	Ambrose Z, Julias JG, Boyer PL, Kewalramani VN, Hughes SH	2006
In vitro analysis of human immunodeficiency virus type 1 minus-strand strong-stop DNA synthesis and genomic RNA processing.	Driscoll MD, Golinelli MP, Hughes SH	2001
Placement of tRNA primer on the primer-binding site requires pol gene expression in avian but not murine retroviruses.	Fu W, Ortiz-Conde BA, Gorelick RJ, Hughes SH, Rein A	1997
Multiple biological roles associated with the Rous sarcoma virus 5' untranslated RNA U5-IR stem and loop.	Miller JT, Ge Z, Morris S, Das K, Leis J	1997
Release of RNA polymerase from vero cell mitochondria after herpes simplex virus type 1 infection.	Tsurumi T, Lehman IR	1990
Cellular factors required for papillomavirus DNA replication.	Melendy T, Sedman J, Stenlund A	1995
TMC125 displays a high genetic barrier to the development of resistance: evidence from in vitro selection experiments.	Vingerhoets J, Azijn H, Fransen E, De Baere I, Smeulders L, Jochmans D, Andries K, Pauwels R, De Béthune MP	2005
Recovery of infectious human immunodeficiency virus type 1 after fusion of defectively infected clones of U-937 cells.	Boulerice F, Li XG, Lvovich A, Wainberg MA	1991
The phenylmethylthiazolylthiourea nonnucleoside reverse transcriptase (RT) inhibitor MSK-076 selects for a resistance mutation in the active site of human immunodeficiency virus type 2 RT.	Auwerx J, Stevens M, Van Rompay AR, Bird LE, Ren J, De Clercq E, Oberg B, Stammers DK, Karlsson A, Balzarini J	2004
A novel genetic pathway of human immunodeficiency virus type 1 resistance to stavudine mediated by the K65R mutation.	García-Lerma JG, MacInnes H, Bennett D, Reid P, Nidtha S, Weinstock H, Kaplan JE, Heneine W	2003
Zidovudine-resistant human immunodeficiency virus selected by passage in cell culture.	Larder BA, Coates KE, Kemp SD	1991
High-level resistance to 3'-azido-3'-deoxythimidine due to a deletion in the reverse transcriptase gene of human immunodeficiency virus type 1.	Imamichi T, Sinha T, Imamichi H, Zhang YM, Metcalf JA, Falloon J, Lane HC	2000
Diminished RNA primer usage associated with the L74V and M184V mutations in the reverse transcriptase of human immunodeficiency virus type 1 provides a possible mechanism for diminished viral replication capacity.	Diallo K, Marchand B, Wei X, Cellai L, Götte M, Wainberg MA	2003
Treatment of human immunodeficiency virus type 1 (HIV-1)-infected cells with combinations of HIV-1-specific inhibitors results in a different resistance pattern than does treatment with single-drug therapy.	Balzarini J, Karlsson A, Pérez-Pérez MJ, Camarasa MJ, Tarpley WG, De Clercq E	1993
In vitro selection of variants of human immunodeficiency virus type 1 resistant to 3'-azido-3'-deoxythymidine and 2',3'-dideoxyinosine.	Gao Q, Gu ZX, Parniak MA, Li XG, Wainberg MA	1992
An in vivo mutation from leucine to tryptophan at position 210 in human immunodeficiency virus type 1 reverse transcriptase contributes to high-level resistance to 3'-azido-3'-deoxythymidine.	Hooker DJ, Tachedjian G, Solomon AE, Gurusinghe AD, Land S, Birch C, Anderson JL, Roy BM, Arnold E, Deacon NJ	1996
Role of homodimerization of human cytomegalovirus DNA polymerase accessory protein UL44 in origin-dependent DNA replication in cells.	Sinigalia E, Alvisi G, Mercorelli B, Coen DM, Pari GS, Jans DA, Ripalti A, Palù G, Loregian A	2008
Mutations that specifically impair the DNA binding activity of the herpes simplex virus protein UL42.	Chow CS, Coen DM	1995
Viral resistance to human immunodeficiency virus type 1-specific pyridinone reverse transcriptase inhibitors.	Nunberg JH, Schleif WA, Boots EJ, O'Brien JA, Quintero JC, Hoffman JM, Emini EA, Goldman ME	1991
Nevirapine resistance mutations of human immunodeficiency virus type 1 selected during therapy.	Richman DD, Havlir D, Corbeil J, Looney D, Ignacio C, Spector SA, Sullivan J, Cheeseman S, Barringer K, Pauletti D	1994
Characteristics of the Pro225His mutation in human immunodeficiency virus type 1 (HIV-1) reverse transcriptase that appears under selective pressure of dose-escalating quinoxaline treatment of HIV-1.	Pelemans H, Esnouf R, Dunkler A, Parniak MA, Vandamme AM, Karlsson A, De Clercq E, Kleim JP, Balzarini J	1997
Reduced susceptibility of human immunodeficiency virus type 1 (HIV-1) from patients with primary HIV infection to nonnucleoside reverse transcriptase inhibitors is associated with variation at novel amino acid sites.	Brown AJ, Precious HM, Whitcomb JM, Wong JK, Quigg M, Huang W, Daar ES, D'Aquila RT, Keiser PH, Connick E, Hellmann NS, Petropoulos CJ, Richman DD, Little SJ	2000
Amino acid substitutions at position 190 of human immunodeficiency virus type 1 reverse transcriptase increase susceptibility to delavirdine and impair virus replication.	Huang W, Gamarnik A, Limoli K, Petropoulos CJ, Whitcomb JM	2003
A mutation in the 3' region of the human immunodeficiency virus type 1 reverse transcriptase (Y318F) associated with nonnucleoside reverse transcriptase inhibitor resistance.	Harrigan PR, Salim M, Stammers DK, Wynhoven B, Brumme ZL, McKenna P, Larder BA, Kemp SD	2002
Involvement of novel human immunodeficiency virus type 1 reverse transcriptase mutations in the regulation of resistance to nucleoside inhibitors.	Svicher V, Sing T, Santoro MM, Forbici F, Rodríguez-Barrios F, Bertoli A, Beerenwinkel N, Bellocchi MC, Gago F, d'Arminio Monforte A, Antinori A, Lengauer T, Ceccherini-Silberstein F, Perno CF	2006
(Alkylamino) piperidine bis(heteroaryl)piperizine analogs are potent, broad-spectrum nonnucleoside reverse transcriptase inhibitors of drug-resistant isolates of human immunodeficiency virus type 1 (HIV-1) and select for drug-resistant variants of HIV-1IIIB with reduced replication phenotypes.	Olmsted RA, Slade DE, Kopta LA, Poppe SM, Poel TJ, Newport SW, Rank KB, Biles C, Morge RA, Dueweke TJ, Yagi Y, Romero DL, Thomas RC, Sharma SK, Tarpley WG	1996
Role for human immunodeficiency virus type 1 Tat protein in suppression of viral reverse transcriptase activity during late stages of viral replication.	Kameoka M, Rong L, Götte M, Liang C, Russell RS, Wainberg MA	2001
HIV-1 and HIV-2 Reverse Transcriptases: Different Mechanisms of Resistance to Nucleoside Reverse Transcriptase Inhibitors.	Boyer PL, Clark PK, Hughes SH	2012
In vitro-selected drug-resistant varicella-zoster virus mutants in the thymidine kinase and DNA polymerase genes yield novel phenotype-genotype associations and highlight differences between antiherpesvirus drugs.	Andrei G, Topalis D, Fiten P, McGuigan C, Balzarini J, Opdenakker G, Snoeck R	2012
Incorporation of human immunodeficiency virus type 1 reverse transcriptase into virus-like particles.	Liao WH, Huang KJ, Chang YF, Wang SM, Tseng YT, Chiang CC, Wang JJ, Wang CT	2007
Isolation and characterization of herpes simplex virus mutants containing engineered mutations at the DNA polymerase locus.	Marcy AI, Yager DR, Coen DM	1990
Effects of modifying the tRNA(3Lys) anticodon on the initiation of human immunodeficiency virus type 1 reverse transcription.	Huang Y, Shalom A, Li Z, Wang J, Mak J, Wainberg MA, Kleiman L	1996
Nucleolin associates with the human cytomegalovirus DNA polymerase accessory subunit UL44 and is necessary for efficient viral replication.	Strang BL, Boulant S, Coen DM	2010
RNA-dependent DNA polymerase activity of RNA tumor viruses. I. Directing influence of DNA in the reaction.	Hurwitz J, Leis JP	1972
Origin of adeno-associated virus DNA replication is a target of carcinogen-inducible DNA amplification.	Yalkinoglu AO, Zentgraf H, Hübscher U	1991
Herpes simplex virus mutants with multiple substitutions affecting DNA binding of UL42 are impaired for viral replication and DNA synthesis.	Jiang C, Hwang YT, Wang G, Randell JC, Coen DM, Hwang CB	2007
A point mutation within a distinct conserved region of the herpes simplex virus DNA polymerase gene confers drug resistance.	Hwang CB, Ruffner KL, Coen DM	1992
RNA-dependent DNA polymerase activity of RNA tumor viruses. II. Directing influence of RNA in the reaction.	Leis JP, Hurwitz J	1972
The carboxy-terminal segment of the human cytomegalovirus DNA polymerase accessory subunit UL44 is crucial for viral replication.	Silva LA, Loregian A, Pari GS, Strang BL, Coen DM	2010
African swine fever virus protein pE296R is a DNA repair apurinic/apyrimidinic endonuclease required for virus growth in swine macrophages.	Redrejo-Rodríguez M, García-Escudero R, Yáñez-Muñoz RJ, Salas ML, Salas J	2006
A screen in Escherichia coli for nucleoside analogs that target human immunodeficiency virus (HIV) reverse transcriptase: coexpression of HIV reverse transcriptase and herpes simplex virus thymidine kinase.	Kim B, Loeb LA	1995
Inhibition of translation by a short element in the 5' leader of the herpes simplex virus 1 DNA polymerase transcript.	Bryant KF, Coen DM	2008
Effects of substitutions of arginine residues on the basic surface of herpes simplex virus UL42 support a role for DNA binding in processive DNA synthesis.	Randell JC, Komazin G, Jiang C, Hwang CB, Coen DM	2005
Evidence for a novel regulatory pathway for herpes simplex virus gene expression in trigeminal ganglion neurons.	Kosz-Vnenchak M, Jacobson J, Coen DM, Knipe DM	1993
Sensitivity of arabinosyladenine-resistant mutants of herpes simplex virus to other antiviral drugs and mapping of drug hypersensitivity mutations to the DNA polymerase locus.	Coen DM, Fleming HE, Leslie LK, Retondo MJ	1985
Mutations in the herpes simplex virus DNA polymerase gene can confer resistance to 9-beta-D-arabinofuranosyladenine.	Coen DM, Furman PA, Gelep PT, Schaffer PA	1982
Differential response of type C and intracisternal type A particle markers in cells treated with iododeoxyuridine and dexamethasone.	Kuff EL, Lueders KK, Orenstein JM, Wilson SH	1976
Herpes simplex virus processivity factor UL42 imparts increased DNA-binding specificity to the viral DNA polymerase and decreased dissociation from primer-template without reducing the elongation rate.	Weisshart K, Chow CS, Coen DM	1999
Functional analysis of the herpes simplex virus UL42 protein.	Digard P, Chow CS, Pirrit L, Coen DM	1993
Analysis of the transcript of the herpes simplex virus DNA polymerase gene provides evidence that polymerase expression is inefficient at the level of translation.	Yager DR, Coen DM	1988
Fine mapping and molecular cloning of mutations in the herpes simplex virus DNA polymerase locus.	Coen DM, Aschman DP, Gelep PT, Retondo MJ, Weller SK, Schaffer PA	1984
Characterization of a replication-competent, integrase-defective human immunodeficiency virus (HIV)/simian virus 40 chimera as a powerful tool for the discovery and validation of HIV integrase inhibitors.	Daelemans D, Lu R, De Clercq E, Engelman A	2007
Feline immunodeficiency virus reverse transcriptase: expression, functional characterization, and reconstitution of the 66- and 51-kilodalton subunits.	Amacker M, Hottiger M, Hübscher U	1995
Characterization of the uracil-DNA glycosylase activity of Epstein-Barr virus BKRF3 and its role in lytic viral DNA replication.	Lu CC, Huang HT, Wang JT, Slupphaug G, Li TK, Wu MC, Chen YC, Lee CP, Chen MR	2007
Inhibitory effect of E-5-(2-bromovinyl)-1-beta-D-arabinofuranosyluracil on herpes simplex virus replication and DNA synthesis.	Descamps J, Sehgal RK, De Clercq E, Allaudeen HS	1982
A Mutation Deleting Sequences Encoding the Amino Terminus of human Cytomegalovirus UL84 impairs Interaction with UL44 and Capsid Localization.	Strang BL, Bender BJ, Sharma M, Pesola JM, Sanders RL, Spector DH, Coen DM	2012
The Pre-NH2-Terminal Domain of the Herpes Simplex Virus 1 DNA Polymerase Catalytic Subunit is Required for Efficient Viral Replication.	Terrell SL, Coen DM	2012
Mutations conferring resistance to viral DNA polymerase inhibitors in camelpox virus give different drug-susceptibility profiles in vaccinia virus.	Duraffour S, Andrei G, Topalis D, Krečmerová M, Crance JM, Garin D, Snoeck R	2012
The Tat protein of human immunodeficiency virus type 1 (HIV-1) can promote placement of tRNA primer onto viral RNA and suppress later DNA polymerization in HIV-1 reverse transcription.	Kameoka M, Morgan M, Binette M, Russell RS, Rong L, Guo X, Mouland A, Kleiman L, Liang C, Wainberg MA	2002
Sequence-specific inhibition of gene expression by a novel antisense oligodeoxynucleotide phosphorothioate directed against a nonregulatory region of the human immunodeficiency virus type 1 genome.	Anazodo MI, Wainberg MA, Friesen AD, Wright JA	1995
Role of Pr160gag-pol in mediating the selective incorporation of tRNA(Lys) into human immunodeficiency virus type 1 particles.	Mak J, Jiang M, Wainberg MA, Hammarskjöld ML, Rekosh D, Kleiman L	1994
Compensation by the E138K mutation in HIV-1 reverse transcriptase for deficits in viral replication capacity and enzyme processivity associated with the M184I/V mutations.	Xu HT, Asahchop EL, Oliveira M, Quashie PK, Quan Y, Brenner BG, Wainberg MA	2011
Template usage is responsible for the preferential acquisition of the K65R reverse transcriptase mutation in subtype C variants of human immunodeficiency virus type 1.	Coutsinos D, Invernizzi CF, Xu H, Moisi DD, Oliveira M, Brenner BG, Wainberg MA	2009
Reverse transcriptase inhibitors can selectively block the synthesis of differently sized viral DNA transcripts in cells acutely infected with human immunodeficiency virus type 1.	Quan Y, Rong L, Liang C, Wainberg MA	1999
Studies of neutralizing monoclonal antibody to human immunodeficiency virus type 1 reverse transcriptase: antagonistic and synergistic effects in reactions performed in the presence of nucleoside and nonnucleoside inhibitors, respectively.	Gu Z, Li X, Quan Y, Parniak MA, Wainberg MA	1996
Effects of 3'-deoxynucleoside 5'-triphosphate concentrations on chain termination by nucleoside analogs during human immunodeficiency virus type 1 reverse transcription of minus-strand strong-stop DNA.	Arts EJ, Marois JP, Gu Z, Le Grice SF, Wainberg MA	1996
The M184V mutation in reverse transcriptase can delay reversion of attenuated variants of simian immunodeficiency virus.	Whitney JB, Oliveira M, Detorio M, Guan Y, Wainberg MA	2002
Virulence and reduced fitness of simian immunodeficiency virus with the M184V mutation in reverse transcriptase.	Van Rompay KK, Matthews TB, Higgins J, Canfield DR, Tarara RP, Wainberg MA, Schinazi RF, Pedersen NC, North TW	2002
Persistence and fitness of multidrug-resistant human immunodeficiency virus type 1 acquired in primary infection.	Brenner BG, Routy JP, Petrella M, Moisi DD, Oliveira M, Detorio M, Spira B, Essabag V, Conway B, Lalonde RG, Sekaly RP, Wainberg MA	2002
Differential susceptibilities of U-937 cell clones to infection by human immunodeficiency virus type 1.	Boulerice F, Geleziunas R, Bour S, Li HL, D'Addario M, Roulston A, Hiscott J, Wainberg MA	1992
High frequency of isolation of defective human immunodeficiency virus type 1 and heterogeneity of viral gene expression in clones of infected U-937 cells.	Boulerice F, Bour S, Geleziunas R, Lvovich A, Wainberg MA	1990
Virion instability of human immunodeficiency virus type 1 reverse transcriptase (RT) mutated in the protease cleavage site between RT p51 and the RT RNase H domain.	Abram ME, Parniak MA	2005
Nascent human immunodeficiency virus type 1 reverse transcription occurs within an enveloped particle.	Zhang H, Zhang Y, Spicer T, Henrard D, Poiesz BJ	1995
Resistance pattern of human immunodeficiency virus type 1 reverse transcriptase to quinoxaline S-2720.	Balzarini J, Karlsson A, Meichsner C, Paessens A, Riess G, De Clercq E, Kleim JP	1994
The role of Pr55(gag) in the annealing of tRNA3Lys to human immunodeficiency virus type 1 genomic RNA.	Cen S, Huang Y, Khorchid A, Darlix JL, Wainberg MA, Kleiman L	1999
The roles of the human immunodeficiency virus type 1 Pol protein and the primer binding site in the placement of primer tRNA(3Lys) onto viral genomic RNA.	Liang C, Rong L, Morin N, Cherry E, Huang Y, Kleiman L, Wainberg MA	1997
The importance of the A-rich loop in human immunodeficiency virus type 1 reverse transcription and infectivity.	Liang C, Li X, Rong L, Inouye P, Quan Y, Kleiman L, Wainberg MA	1997
Human immunodeficiency virus Type 1 nucleocapsid protein (NCp7) directs specific initiation of minus-strand DNA synthesis primed by human tRNA(Lys3) in vitro: studies of viral RNA molecules mutated in regions that flank the primer binding site.	Li X, Quan Y, Arts EJ, Li Z, Preston BD, de Rocquigny H, Roques BP, Darlix JL, Kleiman L, Parniak MA, Wainberg MA	1996
Conditional infectivity of a human immunodeficiency virus matrix domain deletion mutant.	Wang CT, Zhang Y, McDermott J, Barklis E	1993
High sequence conservation of human immunodeficiency virus type 1 reverse transcriptase under drug pressure despite the continuous appearance of mutations.	Ceccherini-Silberstein F, Gago F, Santoro MM, Gori C, Svicher V, Rodríguez-Barrios F, d'Arrigo R, Ciccozzi M, Bertoli A, d'Arminio Monforte A, Balzarini J, Antinori A, Perno CF	2005
Exploitation of the low fidelity of human immunodeficiency virus type 1 (HIV-1) reverse transcriptase and the nucleotide composition bias in the HIV-1 genome to alter the drug resistance development of HIV.	Balzarini J, Camarasa MJ, Pérez-Pérez MJ, San-Félix A, Velázquez S, Perno CF, De Clercq E, Anderson JN, Karlsson A	2001
Cidofovir resistance in vaccinia virus is linked to diminished virulence in mice.	Andrei G, Gammon DB, Fiten P, De Clercq E, Opdenakker G, Snoeck R, Evans DH	2006
Resistance of human immunodeficiency virus type 1 to the high-mannose binding agents cyanovirin N and concanavalin A.	Witvrouw M, Fikkert V, Hantson A, Pannecouque C, O'keefe BR, McMahon J, Stamatatos L, De Clercq E, Bolmstedt A	2005
Selection and characterization of Autographa californica multiple nucleopolyhedrovirus DNA polymerase mutations.	Feng G, Thumbi DK, de Jong J, Hodgson JJ, Arif BM, Doucet D, Krell PJ	2012
Pin1 interacts with the Epstein-Barr virus DNA polymerase catalytic subunit and regulates viral DNA replication.	Narita Y, Murata T, Ryo A, Kawashima D, Sugimoto A, Kanda T, Kimura H, Tsurumi T	2013
Synthesis of viral and host DNA in isolated chromatin from herpes simplex virus-infected HeLa cells.	Yamada M, Brun G, Weissbach A	1978
Purification of avian myeloblastosis virus DNA polymerase by affinity chromatography on polycytidylate-agarose.	Marcus SL, Modak MJ, Cavalieri LF	1974
Reverse transcriptase-associated RNase H activity. II. Inhibition by natural and synthetic RNA.	Marcus SL, Smith SW, Modak MJ	1978
Specific inhibition of DNA polymerase-associated RNase H by DNA.	Modak MJ, Marcus SL	1977
Involvement of the reparative DNA polymerase pol X of African swine fever virus in the maintenance of viral genome stability in vivo.	Redrejo-Rodríguez M, Rodríguez JM, Suárez C, Salas J, Salas ML	2013
Nuclear transport of Epstein-Barr virus DNA polymerase is dependent on the BMRF1 polymerase processivity factor and molecular chaperone Hsp90.	Kawashima D, Kanda T, Murata T, Saito S, Sugimoto A, Narita Y, Tsurumi T	2013

Showing 1 to 127 of 127 entries